Effects of monoamine oxidase inhibitors and/or L-DOPA on neurons in substantia nigra of MPTP-treated mice

被引：0
|
作者：
Fukuda, T [1 ]
Tanaka, J [1 ]
机构：
[1] JIKEI UNIV,SCH MED,DIV NEUROPATHOL,DEPT NEUROSCI,RES CTR MED SCI,MINATO KU,TOKYO,JAPAN
来源：
BRAIN PATHOLOGY | 1997年 / 7卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1389 / 1389
页数：1
相关论文
共 50 条
  • [21] L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates
    M. Kuoppamäki
    G. Al-Barghouthy
    M. J. Jackson
    L. A. Smith
    N. Quinn
    P. Jenner
    Journal of Neural Transmission, 2007, 114 : 1147 - 1153
  • [22] Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys
    DiMonte, DA
    DeLanney, LE
    Irwin, I
    Royland, JE
    Chan, P
    Jakowec, MW
    Langston, JW
    BRAIN RESEARCH, 1996, 738 (01) : 53 - 59
  • [23] CHARACTERIZATION OF DYSKINESIAS INDUCED BY L-DOPA IN MPTP-TREATED SQUIRREL-MONKEYS
    BOYCE, S
    RUPNIAK, NMJ
    STEVENTON, MJ
    IVERSEN, SD
    PSYCHOPHARMACOLOGY, 1990, 102 (01) : 21 - 27
  • [24] Beginning-of-dose and rebound worsening in MPTP-treated common marmosets treated with L-dopa
    Kuoppamaki, M
    Al-Barghouthy, G
    Jackson, M
    Smith, L
    Zeng, BY
    Quinn, N
    MOVEMENT DISORDERS, 2002, 17 : S18 - S18
  • [25] Differential effects of ropinirole, bromocriptine and L-DOPA on striatal preprodynorphin mrna expression in the MPTP-treated marmoset
    Tel, BC
    Cannizzaro, C
    Pearce, RKB
    Rose, S
    Jenner, P
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128
  • [26] Effects of repeated treatment with combinations of L-DOPA and ropinirole on dyskinesia induction in MPTP-treated common marmosets
    Maratos, E
    Smith, L
    Jackson, MJ
    Pearce, RKB
    Jenner, P
    Marsden, CD
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 : U145 - U145
  • [27] Effects of repeated treatment with L-DOPA, bromocriptine and ropinirole in drug naive MPTP-treated common marmosets
    Pearce, RKB
    Banerji, T
    Jenner, P
    Marsden, CD
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 : P37 - P37
  • [28] EVIDENCE THAT THE SUBSTANTIA NIGRA IS A SITE OF ACTION FOR L-DOPA
    ROBERTSON, GS
    ROBERTSON, HA
    NEUROSCIENCE LETTERS, 1988, 89 (02) : 204 - 208
  • [29] Inducing dyskinesia in MPTP-treated common marmosets: The effects of repeated treatment with combinations of L-dopa and ropinirole
    Maratos, E
    Smith, L
    Jackson, MJ
    Pearce, RKB
    Jenner, P
    Marsden, CD
    NEUROLOGY, 1998, 50 (04) : A135 - A135
  • [30] Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice
    Obuchowicz, E
    Antkiewicz-Michaluk, L
    Romanska, I
    Herman, ZS
    JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (12) : 1375 - 1391
12345